Skip to main content
OpenTrials

Clinical trial condition

Depression

Explore clinical trials studying Depression. Study availability and eligibility vary by location and protocol.

6,400 public trials 890 recruiting studies
Refine in advanced search Browse all conditions

Depression trial results

Completed

Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo and Active Control in Major Depressive Disorder

NCT00321490

Conditions
Behavior, Behavioral Symptoms, Depression, +5 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Scottsdale, Arizona, United States
  • Research Site Beverly Hills, California, United States
  • Research Site San Diego, California, United States
View all 34 locations
View Trial Details
Completed

Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in Combination With an Antidepressant in the Treatment of Major Depressive Disorders

NCT00326105

Conditions
Behavior, Behavioral Symptoms, Depression, +5 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site El Centro, California, United States
  • Research Site Irvine, California, United States
  • Research Site Oceanside, California, United States
View all 56 locations
View Trial Details
Completed

Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in the Treatment of Major Depressive Disorders

NCT00326144

Conditions
Behavior, Behavioral Symptoms, Depression, +5 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Little Rock, Arkansas, United States
  • Research Site Anaheim, California, United States
  • Research Site El Centro, California, United States
View all 34 locations
View Trial Details
Completed

Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Major Depressive Disorder

NCT00320268

Conditions
Behavior, Behavioral Symptoms, Depression, +5 more
Locations
  • Research Site Little Rock, Arkansas, United States
  • Research Site Newport Beach, California, United States
  • Research Site Northridge, California, United States
  • Research Site Oceanside, California, United States
View all 37 locations
View Trial Details
Completed

An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Elderly Patients With Depression

NCT00319709

Conditions
Behavior, Behavioral Symptoms, Depression, +3 more
Locations
  • Sanofi-Aventis Administrative Office Sofia, Bulgaria
  • Sanofi-Aventis Administrative Office Helsinki, Finland
  • Sanofi-Aventis Administrative Office Bucharest, Romania
  • Sanofi-Aventis Administrative Office Belgrade, Serbia
View Trial Details
Completed

A Study of SR58611A in the Prevention of Depression Relapse in Patients With Major Depressive Disorder

NCT00345098

Conditions
Behavior, Behavioral Symptoms, Depression, +5 more
Locations
  • Sanofi-Aventis Administrative Office Buenos Aires, Argentina
  • Sanofi-Aventis Administrative Office Sofia, Bulgaria
  • Sanofi-Aventis Administrative Office Zagreb, Croatia
  • Sanofi-Aventis Administrative Office Prague, Czechia
View all 13 locations
View Trial Details

Related conditions